发明名称 TAMPER PREVENTING DOSAGE FORM
摘要 <P>PROBLEM TO BE SOLVED: To provide tamper preventing controlled release formulations capable of preventing the separation of an opioid agonist from an opioid antagonist from dosage forms comprising the opioid agonist and the opioid antagonist by simple extraction methods, commonly used by abusers. <P>SOLUTION: A controlled release dosage form comprises a homogeneous controlled release matrix formulation comprising a hydrophobic material, comprising at least one hydrophobic polymer and at least one fatty alcohol or fatty acid, and the therapeutic amount of an opioid agonist and the sufficient amount of opioid antagonist. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2012255019(A) 申请公布日期 2012.12.27
申请号 JP20120184721 申请日期 2012.08.24
申请人 EURO-CELTIQUE SA 发明人 FLEISCHER WOLFGANG;LEUNER CHRISTIAN;SCHERER SABINE
分类号 A61K31/485;A61K9/20;A61K47/10;A61K47/12;A61K47/38 主分类号 A61K31/485
代理机构 代理人
主权项
地址